A resolution designating July 17, 2024, as "Glioblastoma Awareness Day".

Bill 118 sres 735, also known as the resolution designating July 17, 2024, as "Glioblastoma Awareness Day," aims to bring attention to the devastating effects of glioblastoma, a rare and aggressive form of brain cancer. The resolution highlights the need for increased awareness, research, and support for individuals and families affected by this disease.

Glioblastoma is known for its high mortality rate and limited treatment options, making it a particularly challenging cancer to treat. By designating July 17th as Glioblastoma Awareness Day, the resolution seeks to raise awareness about the impact of this disease on patients and their loved ones, as well as the urgent need for more research and resources to improve outcomes for those affected.

The resolution emphasizes the importance of early detection, access to quality care, and ongoing support for individuals living with glioblastoma. It also recognizes the efforts of healthcare providers, researchers, and advocates working to advance understanding and treatment of this complex and devastating cancer. Overall, Bill 118 sres 735 serves as a call to action for increased awareness and support for individuals and families affected by glioblastoma, with the goal of ultimately improving outcomes and quality of life for those living with this challenging disease.